Symbols / EXOZ Stock $10.33 -2.59% eXoZymes, Inc.

Healthcare • Biotechnology • United States • NCM
EXOZ (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Michael Heltzen
Exch · Country NCM · United States
Market Cap 87.44M
Enterprise Value 85.75M
Income -9.16M
Sales —
FCF (ttm) -3.63M
Book/sh 0.40
Cash/sh 0.36
Employees 32
Insider 10d —
IPO Nov 13, 2024
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S —
P/B 25.56
P/C —
EV/EBITDA -9.10
EV/Sales —
Quick Ratio 2.27
Current Ratio 2.51
Debt/Eq 36.59
LT Debt/Eq —
EPS (ttm) -1.09
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA -63.90%
ROE -132.56%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 8.47M
Shs Float 6.32M
Insider Own 71.12%
Instit Own 0.74%
Short Float 0.28%
Short Ratio 1.63
Short Interest 11.61K
52W High 18.40
vs 52W High -43.89%
52W Low 7.08
vs 52W Low 45.83%
Beta —
Impl. Vol. —
Rel Volume 0.24
Avg Volume 4.32K
Volume 1.04K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $10.60
Price $10.32
Change -2.59%
About

eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$10.33
Latest analyst target
3. DCF / Fair value
$-7.71
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$10.33
Low
—
High
—
Mean
—
News
RSS: Latest EXOZ news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-09 KORMAN TYLER PH.D. Officer — 1,500 $10.04 $15,424
2026-04-01 OPGENORTH PAUL HIDEO Officer — 3,999 $8.44 $33,752
2026-04-01 NAWAZ FOUAD Officer — 5,999 $8.44 $50,632
2026-04-01 KORMAN TYLER PH.D. Officer — 5,332 $8.44 $45,002
2026-04-01 PERRIMAN DAMIEN ALAN MBA Officer — 8,887 $8.44 $75,006
2026-04-01 PERRIMAN DAMIEN ALAN MBA Officer — 62,759 $0.00 $0
2025-07-02 HELTZEN MICHAEL Chief Executive Officer — 1,040 $10.22 $10,629
2025-06-16 KORMAN TYLER PH.D. Officer — 2,990 $12.54 $37,495
2025-06-13 OPGENORTH PAUL HIDEO Officer — 2,990 $12.54 $37,495
2025-06-13 NAWAZ FOUAD Officer — 3,489 $12.54 $43,752
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
9.72
+63.79%
5.93
+230.25%
1.80
+34.78%
1.33
Research And Development
3.71
+98.37%
1.87
+254.28%
0.53
+40.03%
0.38
Selling General And Administration
6.01
+47.90%
4.06
+203.50%
1.34
+35.98%
0.98
General And Administrative Expense
6.01
+47.90%
4.06
+203.50%
1.34
+35.98%
0.98
Salaries And Wages
3.64
+43.83%
2.53
+324.00%
0.60
+46.06%
0.41
Other Gand A
2.37
+54.58%
1.54
+106.77%
0.74
+28.84%
0.58
Other Operating Expenses
—
—
-0.07
-145.01%
-0.03
Total Expenses
9.72
+63.79%
5.93
+230.25%
1.80
+34.78%
1.33
Operating Income
-9.72
-63.79%
-5.93
-230.25%
-1.80
-34.78%
-1.33
Total Operating Income As Reported
-9.72
-63.79%
-5.93
-230.25%
-1.80
-34.78%
-1.33
EBITDA
-9.43
-66.44%
-5.66
-254.20%
-1.60
-34.97%
-1.18
Normalized EBITDA
-9.43
-66.44%
-5.66
-304.83%
-1.40
-18.09%
-1.18
Reconciled Depreciation
0.29
+7.70%
0.27
+35.77%
0.20
+33.29%
0.15
EBIT
-9.72
-63.79%
-5.93
-230.25%
-1.80
-34.78%
-1.33
Total Unusual Items
—
-0.00
+100.00%
-0.20
0.00
Total Unusual Items Excluding Goodwill
—
-0.00
+100.00%
-0.20
0.00
Special Income Charges
—
—
—
0.00
Other Special Charges
—
—
—
—
Net Income
-9.16
-56.26%
-5.86
-187.55%
-2.04
-46.00%
-1.40
Pretax Income
-9.26
-58.05%
-5.86
-193.64%
-2.00
-49.80%
-1.33
Net Non Operating Interest Income Expense
0.36
+368.72%
0.08
+77512.00%
0.00
+2.04%
0.00
Net Interest Income
0.36
+368.72%
0.08
+77512.00%
0.00
+2.04%
0.00
Interest Income Non Operating
—
—
0.00
+2.04%
0.00
Interest Income
—
—
0.00
+2.04%
0.00
Other Income Expense
0.09
+1397.08%
-0.01
+96.58%
-0.20
—
Other Non Operating Income Expenses
0.09
+1398.60%
-0.01
—
—
Gain On Sale Of Security
—
-0.00
+100.00%
-0.20
—
Tax Provision
-0.11
0.00
-100.00%
0.04
-33.50%
0.06
Tax Rate For Calcs
0.00
0.00
-100.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
+100.00%
-0.04
0.00
Net Income Including Noncontrolling Interests
-9.16
-56.26%
-5.86
-187.55%
-2.04
-46.00%
-1.40
Net Income From Continuing Operation Net Minority Interest
-9.16
-56.26%
-5.86
-187.55%
-2.04
-46.00%
-1.40
Net Income From Continuing And Discontinued Operation
-9.16
-56.26%
-5.86
-187.55%
-2.04
-46.00%
-1.40
Net Income Continuous Operations
-9.16
-56.26%
-5.86
-187.55%
-2.04
-46.00%
-1.40
Normalized Income
-9.16
-56.26%
-5.86
-211.71%
-1.88
-34.69%
-1.40
Net Income Common Stockholders
-9.16
-56.26%
-5.86
-187.55%
-2.04
-46.00%
-1.40
Diluted EPS
—
-0.89
-254.86%
-0.25
-46.00%
-0.17
Basic EPS
—
-0.89
-254.86%
-0.25
-46.00%
-0.17
Basic Average Shares
—
6.56
-19.24%
8.13
+0.00%
8.13
Diluted Average Shares
—
6.56
-19.24%
8.13
+0.00%
8.13
Diluted NI Availto Com Stockholders
-9.16
-56.26%
-5.86
-187.55%
-2.04
-46.00%
-1.40
Total Other Finance Cost
-0.36
-368.72%
-0.08
-77512.00%
-0.00
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
5.97
-54.19%
13.03
+266.29%
3.56
+32.50%
2.69
Current Assets
3.94
-63.59%
10.82
+791.58%
1.21
-17.40%
1.47
Cash Cash Equivalents And Short Term Investments
3.04
-68.73%
9.72
+14508.25%
0.07
-88.09%
0.56
Cash And Cash Equivalents
3.04
-68.73%
9.72
+14508.25%
0.07
-88.09%
0.56
Cash Financial
3.04
-68.73%
9.72
+14508.25%
0.07
—
Receivables
0.52
-29.83%
0.74
-16.44%
0.88
+8.99%
0.81
Other Receivables
0.52
-29.83%
0.74
-16.44%
0.88
+8.99%
0.81
Other Current Assets
0.38
+5.25%
0.36
+37.40%
0.26
+161.79%
0.10
Total Non Current Assets
2.03
-8.22%
2.21
-5.58%
2.34
+92.77%
1.22
Net PPE
1.93
-12.98%
2.21
-5.58%
2.34
+92.77%
1.22
Gross PPE
2.94
+0.02%
2.94
+4.86%
2.81
+89.51%
1.48
Accumulated Depreciation
-1.02
-39.52%
-0.73
-57.96%
-0.46
-74.49%
-0.26
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.05
+0.00%
0.05
+9.03%
0.05
+554.21%
0.01
Other Properties
2.56
-1.88%
2.61
+5.33%
2.48
+76.68%
1.40
Leases
0.33
+17.78%
0.28
+0.00%
0.28
+292.58%
0.07
Non Current Accounts Receivable
0.11
—
—
—
Total Liabilities Net Minority Interest
2.57
-1.51%
2.61
-33.71%
3.94
+200.26%
1.31
Current Liabilities
1.57
+17.53%
1.33
-44.80%
2.42
+280.75%
0.63
Payables And Accrued Expenses
1.24
+12.46%
1.10
-7.32%
1.19
+143.24%
0.49
Payables
1.24
+12.46%
1.10
-7.32%
1.19
+143.24%
0.49
Accounts Payable
1.24
+33.66%
0.92
+31.49%
0.70
+82.20%
0.39
Total Tax Payable
—
0.00
-100.00%
0.04
-33.50%
0.06
Income Tax Payable
—
—
0.04
-33.50%
0.06
Current Debt And Capital Lease Obligation
0.33
+41.82%
0.23
+2.24%
0.22
+55.16%
0.15
Current Capital Lease Obligation
0.33
+41.82%
0.23
+2.24%
0.22
+55.16%
0.15
Other Current Liabilities
—
—
1.00
—
Total Non Current Liabilities Net Minority Interest
1.01
-21.32%
1.28
-16.18%
1.53
+125.05%
0.68
Long Term Debt And Capital Lease Obligation
0.92
-20.73%
1.16
-16.59%
1.39
+199.03%
0.46
Long Term Capital Lease Obligation
0.92
-20.73%
1.16
-16.59%
1.39
+199.03%
0.46
Non Current Deferred Liabilities
0.09
-26.88%
0.12
-12.17%
0.14
-34.56%
0.21
Non Current Deferred Revenue
—
—
0.14
-34.56%
0.21
Stockholders Equity
3.40
-67.40%
10.42
+2811.49%
-0.38
-128.00%
1.37
Common Stock Equity
3.40
-67.40%
10.42
+2811.49%
-0.38
-128.00%
1.37
Capital Stock
0.00
+0.00%
0.00
+33.33%
0.00
+0.00%
0.00
Common Stock
0.00
+0.00%
0.00
+33.33%
0.00
+0.00%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
8.41
+0.46%
8.37
+2.96%
8.13
+0.00%
8.13
Ordinary Shares Number
8.41
+0.46%
8.37
+2.96%
8.13
+0.00%
8.13
Additional Paid In Capital
24.50
+9.55%
22.37
+292.38%
5.70
+5.20%
5.42
Retained Earnings
-21.10
-76.67%
-11.95
-96.33%
-6.08
-50.38%
-4.05
Total Equity Gross Minority Interest
3.40
-67.40%
10.42
+2811.49%
-0.38
-128.00%
1.37
Total Capitalization
3.40
-67.40%
10.42
+2811.49%
-0.38
-128.00%
1.37
Working Capital
2.37
-74.99%
9.49
+889.49%
-1.20
-243.93%
0.83
Invested Capital
3.40
-67.40%
10.42
+2811.49%
-0.38
-128.00%
1.37
Total Debt
1.24
-10.35%
1.39
-13.96%
1.61
+164.77%
0.61
Capital Lease Obligations
1.24
-10.35%
1.39
-13.96%
1.61
+164.77%
0.61
Net Tangible Assets
3.40
-67.40%
10.42
+2811.49%
-0.38
-128.00%
1.37
Tangible Book Value
3.40
-67.40%
10.42
+2811.49%
-0.38
-128.00%
1.37
Dueto Related Parties Current
0.01
-97.02%
0.18
-59.79%
0.45
+1012.82%
0.04
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-6.50
+23.56%
-8.51
-620.29%
-1.18
+6.06%
-1.26
Cash Flow From Continuing Operating Activities
-6.50
+23.56%
-8.51
-620.29%
-1.18
+6.06%
-1.26
Net Income From Continuing Operations
-9.16
-56.26%
-5.86
-187.55%
-2.04
-46.00%
-1.40
Depreciation Amortization Depletion
0.29
+7.70%
0.27
+35.77%
0.20
+33.29%
0.15
Depreciation
0.29
+7.70%
0.27
+35.77%
0.20
+33.29%
0.15
Depreciation And Amortization
0.29
+7.70%
0.27
+35.77%
0.20
+33.29%
0.15
Other Non Cash Items
0.00
+102.34%
-0.02
+52.98%
-0.04
-17.41%
-0.04
Stock Based Compensation
1.99
+76.62%
1.13
+299.82%
0.28
+30.04%
0.22
Operating Gains Losses
—
0.00
-100.00%
0.20
—
Gain Loss On Investment Securities
—
0.00
-100.00%
0.20
—
Change In Working Capital
0.38
+109.46%
-4.02
-1923.73%
0.22
+215.91%
-0.19
Change In Receivables
0.11
-20.90%
0.15
+299.26%
-0.07
+78.67%
-0.34
Change In Prepaid Assets
-0.02
+80.72%
-0.10
+39.48%
-0.16
-130.62%
-0.07
Change In Payables And Accrued Expense
0.28
+107.00%
-4.06
-989.80%
0.46
+105.68%
0.22
Change In Payable
0.28
+107.00%
-4.06
-989.80%
0.46
+105.68%
0.22
Change In Account Payable
0.31
+40.55%
0.22
-18.89%
0.27
+130.29%
0.12
Investing Cash Flow
-0.15
+58.18%
-0.36
-15.44%
-0.31
-256.80%
-0.09
Cash Flow From Continuing Investing Activities
-0.15
+58.18%
-0.36
-15.44%
-0.31
-256.80%
-0.09
Net PPE Purchase And Sale
-0.17
+57.14%
-0.40
-37.32%
-0.29
-55.24%
-0.19
Purchase Of PPE
-0.17
+57.14%
-0.40
-37.32%
-0.29
-55.24%
-0.19
Capital Expenditure
-0.17
+57.14%
-0.40
-37.32%
-0.29
-55.24%
-0.19
Net Other Investing Changes
0.02
-47.10%
0.04
+265.82%
-0.02
-122.73%
0.10
Financing Cash Flow
-0.03
-100.15%
18.52
+1751.76%
1.00
-26.20%
1.36
Cash Flow From Continuing Financing Activities
-0.03
-100.15%
18.52
+1751.76%
1.00
-26.20%
1.36
Net Issuance Payments Of Debt
-0.03
0.00
—
—
Repayment Of Debt
-0.03
0.00
—
—
Long Term Debt Payments
-0.03
0.00
—
—
Net Long Term Debt Issuance
-0.03
0.00
—
—
Net Common Stock Issuance
0.00
-100.00%
14.53
0.00
-100.00%
1.36
Proceeds From Stock Option Exercised
0.00
-100.00%
0.01
0.00
—
Net Other Financing Charges
—
3.98
+297.69%
1.00
—
Changes In Cash
-6.68
-169.20%
9.65
+2061.80%
-0.49
-4671.14%
0.01
Beginning Cash Position
9.72
+14508.25%
0.07
-88.09%
0.56
+1.96%
0.55
End Cash Position
3.04
-68.73%
9.72
+14508.25%
0.07
-88.09%
0.56
Free Cash Flow
-6.67
+25.05%
-8.90
-505.76%
-1.47
-1.84%
-1.44
Interest Paid Supplemental Data
—
—
0.00
0.00
Income Tax Paid Supplemental Data
0.00
0.00
-100.00%
0.06
0.00
Change In Income Tax Payable
0.00
+100.00%
-0.04
-98.51%
-0.02
-133.50%
0.06
Change In Tax Payable
0.00
+100.00%
-0.04
-98.51%
-0.02
-133.50%
0.06
Common Stock Issuance
0.00
-100.00%
14.53
0.00
-100.00%
1.36
Issuance Of Capital Stock
0.00
-100.00%
14.53
0.00
-100.00%
1.36
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category